NCT05064696 is a NA clinical trial of Non-stick gauze dressing in Total Ankle Arthroplasty, sponsored by Walter C Hembree.

Who is sponsoring NCT05064696?

NCT05064696 is sponsored by Walter C Hembree.

What drugs are being tested in NCT05064696?

Interventions in NCT05064696: Non-stick gauze dressing, PICO dressing.

What condition does NCT05064696 study?

NCT05064696 studies Total Ankle Arthroplasty.

Is NCT05064696 still recruiting?

NCT05064696 is currently status unknown. Last updated 21 September 2023.

Last reviewed 2023-09-21 · How we verify

NCT05064696

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

PICO- Single-use Negative Pressure Wound Therapy System

Status unknown NA Last updated 21 September 2023

What this trial tests

NA trial testing Non-stick gauze dressing in Total Ankle Arthroplasty in 150 participants. Status unknown.

Timeline

25 August 2021

Primary endpoint
30 September 2024

30 September 2025

Quick facts

Lead sponsor	Walter C Hembree
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	150
Start date	25 August 2021
Primary completion	30 September 2024
Estimated completion	30 September 2025
Sites	1 location across United States

Drugs / interventions tested

Non-stick gauze dressing
PICO dressing

Conditions studied

Total Ankle Arthroplasty — all drugs for Total Ankle Arthroplasty →

Sponsor

Walter C Hembree

Who can join

18 and older, any sex, with Total Ankle Arthroplasty. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To compare the rate of wound complications with the PICO dressing versus a standard nonstick gauze dressing in patients undergoing anterior total ankle arthroplasty.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Incisional Negative Pressure Wound Therapy devices applied after Total Ankle Arthroplasty: A Hospital-Based Health Technology Assessment.
Atfeh J, Guerre P, Carre E, Besse JL, et al · · 2025 · PMID 40299881 · DOI 10.1371/journal.pone.0322327

Verify or expand the search:

Other recruiting trials for Total Ankle Arthroplasty

Currently open trials in the same condition.

NCT04454203 — Femoral Peri-arterial Local Anesthetic Injection Via Peri-arterial Perineural Catheter Reverses Tourniquet Associated Is · Phase 4 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05064696 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Walter C Hembree
Last refreshed: 21 September 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05064696.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing